We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELZ icon
12476
Creative Medical Technology
CELZ
$7.52M
$50K ﹤0.01%
+2,270
New +$47.6K
EMX
12477
PUT
DELISTED
EMX Royalty
EMX
$50K ﹤0.01%
21,900
+2,600
+13% +$6.66K
FRSX
12478
CALL
Foresight Autonomous Holdings
FRSX
$4.75M
$50K ﹤0.01%
235
-136
-37% -$43.3K
JAGX icon
12479
PUT
Jaguar Health
JAGX
$4.47M
0
NCMI icon
12480
CALL
National CineMedia
NCMI
$235M
$50K ﹤0.01%
1,780
-13,150
-88% -$419K
OSS icon
12481
PUT
One Stop Systems
OSS
$282M
$50K ﹤0.01%
10,000
-3,200
-24% -$16K
REAX icon
12482
PUT
Real REMAX Group Inc. Common Stock
REAX
$515M
$50K ﹤0.01%
+1,350
New +$38.5K
TALK
12483
PUT
DELISTED
Talkspace
TALK
$50K ﹤0.01%
25,400
+7,700
+44% +$22K
SCNX
12484
Scienture Holdings
SCNX
$15.6M
$50K ﹤0.01%
+1,422
New +$78.9K
NBSE
12485
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$50K ﹤0.01%
895
-530
-37% -$35.6K
PNTM.WS
12486
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$50K ﹤0.01%
55,808
-33,613
-38% -$27K
AGRX
12487
DELISTED
Agile Therapeutics
AGRX
$50K ﹤0.01%
51
+5
+11% +$7.05K
ATNX
12488
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$50K ﹤0.01%
1,840
-5,625
-75% -$237K
SVFAW
12489
DELISTED
SVF Investment Corp. Warrant
SVFAW
$50K ﹤0.01%
38,134
-11,850
-24% -$15.7K
IPOD.WS
12490
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$50K ﹤0.01%
24,954
ORPH
12491
CALL
DELISTED
Orphazyme A/S
ORPH
$50K ﹤0.01%
20,900
-20,100
-49% -$71K
AEG icon
12492
PUT
Aegon
AEG
$13.6B
$49K ﹤0.01%
10,456
-7,528
-42% -$35.2K
CTMX icon
12493
CALL
CytomX Therapeutics
CTMX
$745M
$49K ﹤0.01%
+11,300
New +$66.2K
FGB
12494
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
$49K ﹤0.01%
11,991
-3,582
-23% -$14.7K
GSIT icon
12495
PUT
GSI Technology
GSIT
$228M
$49K ﹤0.01%
+10,600
New +$55.8K
LYRA
12496
DELISTED
LYRA THERAPEUTICS INC
LYRA
$49K ﹤0.01%
224
-94
-30% -$30.2K
SIEB icon
12497
CALL
Siebert Financial
SIEB
$81M
$49K ﹤0.01%
21,200
-25,000
-54% -$72.1K
USIO icon
12498
Usio Inc
USIO
$77.2M
$49K ﹤0.01%
+11,341
New +$68.3K
VS icon
12499
Versus Systems
VS
$8.51M
$49K ﹤0.01%
97
-109
-53% -$80.7K
TLIS
12500
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$49K ﹤0.01%
+814
New +$60.9K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.